ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
90 hedge funds and large institutions have $47.5M invested in Endocyte, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-6
Holders Change %
-6.25%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
25
Reduced
31
Closed
9
Calls
$353K
Puts
$54K
Net Calls
+$299K
Net Calls Change
+$83K
Top Buyers
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$2.69M |
| 2 |
Millennium Management
New York
|
$1.38M |
| 3 |
JPMorgan Chase & Co
New York
|
$2.23M |
| 4 |
EGA
Eagle Global Advisors
Houston,
Texas
|
$307K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
$476K |
